Hillhouse boosts Longi position after probe, as it pivots to global focus
The private equity firm was told by China’s securities regulator to buy back shares in the solar company after selling them without the necessary disclosure Key Takeaways: Hillhouse Capital has…
China reaffirms support for offshore IPOs, but new listings likely to remain small
More than 80 companies have successfully registered with China’s securities regulator to list shares in the U.S. and Hong Kong, and another 23 have registered to issue GDRs in Europe…
U.S.-China stock cooperation moves ahead with fines on two PwC China affiliates
The U.S. securities regulator’s accounting arm fined PwC’s Hong Kong and Shanghai units $7 million after hundreds of their workers cheated on online training tests Key Takeaways: The accounting arm…
China-U.S. IPO train creeps ahead with first new listing application
Majestic Ideal Holdings has become the first U.S. listing candidate to advance in a new application process required by China for all Chinese firms seeking to list abroad Key Takeaways:…
U.S. Gives High Marks to First Inspections of New York-listed Chinese Companies
The U.S. securities regulator’s accounting arm said it obtained ‘complete access’ to companies it targeted under a landmark information-sharing agreement reached in AugustKey Takeaways:The PCAOB gave a positive review of…
China, U.S. Stock Regulators Hope New Agreement Will Succeed Where Others Haven’t
New information-sharing deal will give U.S. accounting regulator access to audit records for New York-listed Chinese firms. But will it really get what it wants? Key Takeaways: Having reached a…
FAST NEWS: Fosun Pharma Raises $660 Million in Non-public Placement of A-Shares
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced on Wednesday it plans to raise up to 4.48 billion yuan ($660 million) through a non-public offering of about…